Capitol Counsel LLC on Behalf of Amgen, INC.
Biopharmaceuticals
Based in DC
AI Overview
With $10K in lobbying spend across 4 quarterly filings, Capitol Counsel LLC on Behalf of Amgen, INC is an active lobbying client. Their lobbying covers 1 issue area.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $10K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Capitol Counsel LLC on Behalf of Amgen, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid
Organization focused on biopharmaceuticals and biotechnology.
H.R.3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021,
S. 1943 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.